Tysabri

TABLE OF CONTENTS

4 OVERVIEW
4 Drug Overview
5 Product Profiles
5 Tysabri : Crohn’s disease
16 Tysabri : Multiple sclerosis (MS)

LIST OF FIGURES
9 Figure 5: Patient-based forecast methodology for COPD
10 Figure 10: Anoro for COPD – SWOT analysis
13 Figure 38: Stiolto Respimat for COPD – SWOT analysis
20 Figure 7: Datamonitor Healthcare’s drug assessment summary of Advair for COPD
21 Figure 12: Arcapta for COPD – SWOT analysis
5 Figure 9: Datamonitor Healthcare’s drug assessment summary of Advair for COPD

LIST OF TABLES
7 Table 2: Tysabri pivotal trial data in Crohn’s disease
14 Table 3: Tysabri sales for Crohn’s disease in the US ($m), 2016–25
17 Table 4: Tysabri drug profile
18 Table 5: Tysabri pivotal trial data in multiple sclerosis
25 Table 6: Tysabri sales for multiple sclerosis across the US, Japan, and five major EU markets, by country ($m), 2016–25